Alemtuzumab Intravenous and Succinylcholine Chloride Injection
Determining the interaction of Alemtuzumab Intravenous and Succinylcholine Chloride Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: alemtuzumab
Brand name: Campath, Lemtrada
Synonyms: Alemtuzumab
Generic Name: succinylcholine
Brand name: Anectine, Quelicin
Synonyms: Succinylcholine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Alemtuzumab Intravenous-Suclear
- Alemtuzumab Intravenous-Sucralfate
- Alemtuzumab Intravenous-Sucralfate Oral Suspension
- Alemtuzumab Intravenous-Sucralfate Suspension
- Alemtuzumab Intravenous-Sucralfate Tablet
- Alemtuzumab Intravenous-Sucralfate Tablets
- Succinylcholine Chloride Injection-Alenaze-D
- Succinylcholine Chloride Injection-Alendronate
- Succinylcholine Chloride Injection-Alendronate and cholecalciferol
- Succinylcholine Chloride Injection-Alendronate Effervescent Tablets
- Succinylcholine Chloride Injection-Alendronate Oral Solution
- Succinylcholine Chloride Injection-Alendronate Sodium